Comparative in-vitro activity of cefoperazone-tazobactam and cefoperazone-sulbactam combinations against ESBL pathogens in respiratory and urinary infections

Journal of Association of Physicians of India

Volumn 60, Issue 11, 2012, Pages 22-24

  Patankar, Manjusha ^a   Sukumaran, Sangita ^a   Chhibba, Anita ^a   Nayak, Usha ^a   Sequeira, Loraine ^b  

^a Padmashree Dr DY Patil Medical College   (India)

^b Department of Histopathology   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BETA LACTAMASE; CEFOPERAZONE; DRUG DERIVATIVE; PENICILLANIC ACID; SULBACTAM; TAZOBACTAM;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL INFECTION; COMPARATIVE STUDY; DISK DIFFUSION; DRUG ANTAGONISM; DRUG COMBINATION; HUMAN; INDIA; MICROBIOLOGY; RESPIRATORY TRACT INFECTION; URINARY TRACT INFECTION;

ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BETA-LACTAMASES; CEFOPERAZONE; CEPHALOSPORIN RESISTANCE; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG COMBINATIONS; HUMANS; INDIA; PENICILLANIC ACID; RESPIRATORY TRACT INFECTIONS; SULBACTAM; URINARY TRACT INFECTIONS;

EID: 84869238903     PISSN: 00045772     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Chaudhary U, Aggarwal R. Extended spectrum β-lactamases (ESBL) - an emerging threat to clinical therapeutics. Indian Journal of Medical Microbiology 2004;22:75-80.
2. Payne DJ, Cramp R, Winstanley DJ, Knowles DJC. Comparative Activities of Clavulanic Acid, Sulbactam, and Tazobactam against Clinically Important 3-Lactamases. Antimicrobial Agents And Chemotherapy 1994;38:767-72.
3. Forbes BA, Sahm DF, Weissfeld AS. Bailey and Scotts Diagnostic Microbiology. Mosby, Missouri, USA, 1998.
4. Ananthkrishnan AN, Kanungo R, Kumar A, Badrinath S. Detection of ESBL producers among surgical wound infections and burns patients in JIPMER. Indian J Med Microbiol 2000;18:160-165.
5. Monden Y, Fujimoto Y, Nakahara K, Pharmacokinetics of cefoperazone concentration in human lung tissue. Jpn J Antibiot 1986;39:57-62.
6. Goldstein EJ, Gombert ME, Sierra MF, Butt KM. Cefoperazone therapy of complicated urinary tract infections: pharmacokinetics in renal transplant recipients. Chemotherapy 1985;31:6-12
7. Livermore DM, Hope R, Mushtaq S, Warner M. Orthodox and unorthodox clavulanate combinations against extended-spectrum beta-lactamase producers. Clin Microbiol Infect 2008;14 Suppl 1:189-93.